Deep learning approach enhances HER2 scoring in breast cancer

byUCLA Engineering Institute for Technology AdvancementAutomated HER2 Scoring in Breast Cancer Images Using Deep Learning and Pyramid Sampling. Credit: UCLA Engineering Institute for Technology

Updated on: August 01,2024

Deep learning approach enhances HER2 scoring in breast cancer

byUCLA Engineering Institute for Technology AdvancementAutomated HER2 Scoring in Breast Cancer Images Using Deep Learning and Pyramid Sampling. Credit: UCLA Engineering Institute for Technology

Updated on:August 01,2024

Study shows immunotherapy may benefit a subset of patients with penile cancer

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainPenile cancer is a rare disease with approximately 2,070 new cases each year in the U.S. Treatment options are limited and typical

Updated on: January 22,2024

Study shows immunotherapy may benefit a subset of patients with penile cancer

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainPenile cancer is a rare disease with approximately 2,070 new cases each year in the U.S. Treatment options are limited and typical

Updated on:January 22,2024

A new therapeutic target for metastatic and resistant prostate cancers

by IDIBELL-Bellvitge Biomedical Research InstituteÁlvaro Aytés & Katia Ruggero. Credit: IDIBELLProstate Cancer researchers from the Bellvitge Biomedical Research Institute (IDIBELL), led by D

Updated on: April 01,2024

A new therapeutic target for metastatic and resistant prostate cancers

by IDIBELL-Bellvitge Biomedical Research InstituteÁlvaro Aytés & Katia Ruggero. Credit: IDIBELLProstate Cancer researchers from the Bellvitge Biomedical Research Institute (IDIBELL), led by D

Updated on:April 01,2024

70-gene signature impacts treatment decisions in breast CA

(HealthDay)—The 70-gene signature (GS) assay affects treatment decisions among physicians treating patients identified as being at intermediate risk with the 21-gene assay (21-GA), according to a stud

Updated on: March 14,2024

70-gene signature impacts treatment decisions in breast CA

(HealthDay)—The 70-gene signature (GS) assay affects treatment decisions among physicians treating patients identified as being at intermediate risk with the 21-gene assay (21-GA), according to a stud

Updated on:March 14,2024

Can some cancer patients safely skip radiation therapy? New studies say yes

by Dennis ThompsonRadiation therapy might not be necessary in treating some forms of rectal cancer and lymphoma, sparing patients from the toxic treatment, a pair of new clinical trials shows.One tria

Updated on: February 01,2024

Can some cancer patients safely skip radiation therapy? New studies say yes

by Dennis ThompsonRadiation therapy might not be necessary in treating some forms of rectal cancer and lymphoma, sparing patients from the toxic treatment, a pair of new clinical trials shows.One tria

Updated on:February 01,2024

Scientists find core regulatory circuit controlling identity of aggressive leukemia

bySt. Jude Children's Research HospitalCo-corresponding author Brian J. Abraham, PhD, and co-author Kelsey Maher, PhD. Credit: St. Jude Children's Research HospitalA collaboration betwee

Updated on: March 30,2024

Scientists find core regulatory circuit controlling identity of aggressive leukemia

bySt. Jude Children's Research HospitalCo-corresponding author Brian J. Abraham, PhD, and co-author Kelsey Maher, PhD. Credit: St. Jude Children's Research HospitalA collaboration betwee

Updated on:March 30,2024

Target discovered for the treatment of pancreatic cancer

byKiel UniversityAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA team at the Institute of Biochemistry at Kiel University has found a

Updated on: July 05,2024

Target discovered for the treatment of pancreatic cancer

byKiel UniversityAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA team at the Institute of Biochemistry at Kiel University has found a

Updated on:July 05,2024

New study estimates preventable cancer burden linked to poor diet in the US

by Tufts UniversityA new study estimates that 5.2 percent of new invasive cancer cases reported in 2015 are associated with poor diets. Credit: Nako Kobayashi/Tufts UniversityA new modeling study

Updated on: May 21,2024

New study estimates preventable cancer burden linked to poor diet in the US

by Tufts UniversityA new study estimates that 5.2 percent of new invasive cancer cases reported in 2015 are associated with poor diets. Credit: Nako Kobayashi/Tufts UniversityA new modeling study

Updated on:May 21,2024

New gene implicated in cancer, cellular stress response

by Olivia Dimmer,Northwestern UniversityTissue-restricted expression of mammalian HAPSTR2. a Transcript abundance of HAPSTR1 and HAPSTR2 in the indicated human tissues; GTEx RNA-seq data. TPM, t

Updated on: February 18,2024

New gene implicated in cancer, cellular stress response

by Olivia Dimmer,Northwestern UniversityTissue-restricted expression of mammalian HAPSTR2. a Transcript abundance of HAPSTR1 and HAPSTR2 in the indicated human tissues; GTEx RNA-seq data. TPM, t

Updated on:February 18,2024

Investigators find disparities in mesothelioma survival due to social determinants, limited access

by Sylvester Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainTreatment outcomes for patients with malignant pleural mesothelioma, a rare cancer commonly known as mesothelioma, are often af

Updated on: February 03,2024

Investigators find disparities in mesothelioma survival due to social determinants, limited access

by Sylvester Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainTreatment outcomes for patients with malignant pleural mesothelioma, a rare cancer commonly known as mesothelioma, are often af

Updated on:February 03,2024

Trial: Standard chemoradiation superior to de-intensification approaches for HPV-related oropharyngeal cancer

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainResearchers looking to de-intensify radiation treatments for people with early-stage, HPV-associated oropharyngeal canc

Updated on: October 22,2024

Trial: Standard chemoradiation superior to de-intensification approaches for HPV-related oropharyngeal cancer

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainResearchers looking to de-intensify radiation treatments for people with early-stage, HPV-associated oropharyngeal canc

Updated on:October 22,2024

Researchers develop new one-two punch against melanoma in mouse model

by Johns Hopkins University School of MedicineCredit: Kimmel Cancer CenterResearchers at the Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins and the Johns Hopkins University

Updated on: June 04,2024

Researchers develop new one-two punch against melanoma in mouse model

by Johns Hopkins University School of MedicineCredit: Kimmel Cancer CenterResearchers at the Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins and the Johns Hopkins University

Updated on:June 04,2024